Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
New England Journal of Medicine.
Times cited: 498
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: Results from a multicenter, randomized, controlled trial of vatreptacog alfa.
Journal of Thrombosis and Haemostasis.
Times cited: 43